Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hyperlipoproteinemias
  Free Subscription

Articles published in
Curr Opin Lipidol
    August 2025
  1. THOMPSON GR, Walji S, Cegla J
    Liver transplantation for homozygous familial hypercholesterolaemia.
    Curr Opin Lipidol. 2025 Aug 7. doi: 10.1097/MOL.0000000000001007.
    >> Share

    June 2025
  2. PRAKASH Y, Bhatt DL, Malick WA
    Emerging agents targeting triglycerides.
    Curr Opin Lipidol. 2025;36:119-129.
    >> Share

    April 2025
  3. TADA H, Nohara A, Kawashiri MA, Takamura M, et al
    Impact of Achilles tendon on diagnosis and phenotypes of familial hypercholesterolemia.
    Curr Opin Lipidol. 2025 Apr 14. doi: 10.1097/MOL.0000000000000992.
    >> Share

  4. HEGELE RA
    What is the phenotype of heterozygous lipoprotein lipase deficiency?
    Curr Opin Lipidol. 2025;36:96-103.
    >> Share

    March 2025
  5. ALNOURI F, Raal FJ
    Familial hypercholesterolemia in pregnancy.
    Curr Opin Lipidol. 2025 Mar 7. doi: 10.1097/MOL.0000000000000980.
    >> Share

    December 2024
  6. TAMEHRI ZADEH SS, Pang J, Chan DC, Watts GF, et al
    A contemporary snapshot of familial hypercholesterolemia registries.
    Curr Opin Lipidol. 2024;35:297-302.
    >> Share

    November 2024
  7. BIRKENHEAD K, Sullivan D, Watts GF, Sarkies MN, et al
    Implementation science and genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Nov 26. doi: 10.1097/MOL.0000000000000967.
    >> Share

  8. PAQUETTE M, Guay SP, Baass A
    Genetic determinants of pancreatitis risk in hypertriglyceridemia.
    Curr Opin Lipidol. 2024 Nov 11. doi: 10.1097/MOL.0000000000000962.
    >> Share

    September 2024
  9. RAMASWAMI U, Priestley-Barnham L, Humphries SE
    Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families.
    Curr Opin Lipidol. 2024 Sep 27. doi: 10.1097/MOL.0000000000000952.
    >> Share

    June 2024
  10. BASHIR B, Ferdousi M, Durrington PN, Soran H, et al
    Pancreatic and cardiometabolic complications of severe hypertriglyceridaemia.
    Curr Opin Lipidol. 2024 Jun 7. doi: 10.1097/MOL.0000000000000939.
    >> Share

    April 2024
  11. BRUNHAM LR
    Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?
    Curr Opin Lipidol. 2024 Apr 22. doi: 10.1097/MOL.0000000000000938.
    >> Share

  12. CIVEIRA F, Martin C, Cenarro A
    APOE and familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Apr 17. doi: 10.1097/MOL.0000000000000937.
    >> Share

    February 2024
  13. CHAN DC, Watts GF
    ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
    Curr Opin Lipidol. 2024 Feb 20. doi: 10.1097/MOL.0000000000000920.
    >> Share

  14. VAN DEN BOSCH SE, Hutten BA, Corpeleijn WE, Kusters DM, et al
    Familial hypercholesterolemia in children and the importance of early treatment.
    Curr Opin Lipidol. 2024 Feb 15. doi: 10.1097/MOL.0000000000000926.
    >> Share

  15. ZHANG Y, de Ferranti SD, Moran AE
    Genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Feb 1. doi: 10.1097/MOL.0000000000000925.
    >> Share

    December 2023
  16. PERERA SD, Hegele RA
    Genetic variation in apolipoprotein A-V in hypertriglyceridemia.
    Curr Opin Lipidol. 2023 Dec 21. doi: 10.1097/MOL.0000000000000916.
    >> Share

  17. ROMERO-JIMENEZ MJ, Mansilla-Rodriguez ME, Gutierrez-Cortizo EN
    Predictors of cardiovascular risk in familial hypercholesterolemia.
    Curr Opin Lipidol. 2023;34:272-277.
    >> Share

  18. GILLARD BK, Rosales C, Gotto AM Jr, Pownall HJ, et al
    The pathophysiology of excess plasma-free cholesterol.
    Curr Opin Lipidol. 2023;34:278-286.
    >> Share

  19. KARALIS DG
    Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:252-258.
    >> Share

    November 2023
  20. ROY G, Drouin-Chartier JP
    Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?
    Curr Opin Lipidol. 2023 Nov 2. doi: 10.1097/MOL.0000000000000908.
    >> Share

    August 2023
  21. CHOUDHARI P, Patni N
    Updates in the management of pediatric dyslipidemia.
    Curr Opin Lipidol. 2023;34:156-161.
    >> Share

    June 2023
  22. GANDA OP
    Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:105-113.
    >> Share

  23. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Inflammation compared to low-density lipoprotein cholesterol: two different causes of atherosclerotic cardiovascular disease.
    Curr Opin Lipidol. 2023;34:96-104.
    >> Share

    April 2023
  24. CLARKE SL
    Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
    Curr Opin Lipidol. 2023;34:52-58.
    >> Share

    March 2023
  25. VUORIO A, Raal F, Kovanen PT
    Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-19.
    Curr Opin Lipidol. 2023 Mar 10. doi: 10.1097/MOL.0000000000000876.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016